Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide

NCT04694586 · clinicaltrials.gov ↗
PHASE2
Phase
SUSPENDED
Status
40
Enrollment
OTHER
Sponsor class

Stopped Suspended 15th of Nov 2023 due to conditions affecting recruitment process.

Conditions

Interventions

Sponsor

University Hospital, Linkoeping

Collaborators